HOOKIPA PHARMA INC. Accounts Receivable
HOOKIPA PHARMA INC. had Accounts Receivable of $545.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2025-05-15
- 2025-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $545.00K.
- 2024-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $290.00K.
- 2024-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $324.00K.
- 2024-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $82.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2025-03-31 | $545.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $290.00K 10-Q · filed 2025-05-15 |
| 2024-09-30 | $324.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $82.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $10.21M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $511.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $675.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $255.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $501.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.53M 10-K · filed 2024-03-22 |
| 2022-09-30 | $743.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.19M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $703.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $6.89M 10-K · filed 2023-03-15 |
| 2021-09-30 | $2.52M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.92M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $4.29M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $5.54M 10-K · filed 2022-03-24 |
| 2020-09-30 | $2.96M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $4.74M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $2.81M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.54M 10-K · filed 2021-03-18 |
| 2019-09-30 | $1.27M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.26M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $1.33M 10-Q · filed 2019-05-20 |
| 2018-12-31 | $4.92M 10-K · filed 2020-03-19 |